Death row inmate whose execution was postponed found dead in cell

pharmafile | January 9, 2019 | News story | Research and Development Alvogen, Scott Dozier, execution, pharma, prison 

Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found dead in his cell.

The 48 year old, an inmate on Nevada’s death row, had in July of last year had his execution postponed twice after a Nevada judge temporarily halted the use of the sedative midazolam in executions, following objections from the New Jersey based pharma firm Alvogen.

The case, in which Alvogen claimed that the Nevada Department of Corrections obtained the drug illegaly, saw Dozier’s executions halted just 11 hours before he was scheduled to die.

Speaking to the Associated Press, State Department of Corrections spokeswoman Brooke Santina reported that Dozier had been found dead at 4:35 p.m. on Saturday in his solo cell. The twice convicted killer was reported to have died from an apparent hanging.

Dozier had repeatedly asked to be executed and given up on appeals as he suggested that he would rather die than spend the rest of his life in prison.

Louis Goss

Related Content

FDA approves IMIDEX’s AI-powered device VisiRad XR

The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …

Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo

On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ …


Novartis acquires Chinook Therapeutics for $3.5bn

Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based …

Latest content